Rotavirus vaccine: Current status and future prospects

Indian Journal of Medical Research

Volumn 104, Issue JULY, 1996, Pages 76-85

  Naik, T N ^a   Krishnan, T ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Diarrhoea; Epidemiology; Immunization; Rotavirus; Serotype; Strain diversity; Vaccine

Indexed keywords

INACTIVATED VACCINE; LIVE VACCINE; ROTAVIRUS VACCINE;

GASTROINTESTINAL MUCOSA; GENETIC ENGINEERING; IMMUNE RESPONSE; INFANTILE DIARRHEA; REVIEW; ROTAVIRUS; SEASONAL VARIATION; STRAIN DIFFERENCE;

ANIMALS; HUMANS; ROTAVIRUS; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 0030015810     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Ghosh SK, Naik TN. Evidence for a new rotavirus subgroups in India. Epidemiol Infect 1989; 102 : 523-30.
2. Saha MR, Sen D, Datta P, Datta D, Pal SC. Role of rotavirus as the cause of acute paediatric diarrhoea in Calcutta. Trans R Soc Trop Med Hyg 1984; 78 : 818-20.
3. LeBaron CW, Furutan NP, Lew JF, Allen JR, Gouvea V, Moc C, Monroe SS. Viral agents of gastroenteritis. Public health importance and outbreak management. MMWR 1990; 39 : 1-24.
4. DeZoysa I, Feachem RG. Interventions for the control of diarrhoeal diseases among young children : rotavirus and cholera immunization. Bull, WHO 1985; 63 : 569-83.
5. Conner ME, Matson DO, Estes MK. Rotavirus vaccine and vaccine potential. Curr Top Microbiol Immunol 1994; 185 : 285-337.
6. Kapikian AZ, Flores J, Hoshino Y et al. Rationale for the development of a rotavirus vaccine for infants and young children. In: Progress in vaccinology. New York : Springer-Verlag, 1989; 151-80.
7. Kapikian AZ, Flores J, Midthun K. Hoshiro Y, Green KY, Gorziglia MJ et al. Strategies for the development of a rotavirus vaccine against infantile diarrhoea with an update on clinical trials of rotavirus vaccines. Adv Exp Med Biol 1989; 257 : 67-90.
8. Kapikian AZ, Chanock RM. Rotaviruses. In : Fields BN et al. editor. Virology, 2nd ed. New York : Raven Press, 1990; 1353-1404.
9. Flewett TH, Woode GN. The rotaviruses. Arch Virol 1978; 57 : 1-23.
10. Estes MK, Cohen J. Rotavirus gene structure and function. Microbiol Rev 1989; 53 : 410-49.
11. Desselberger U, McCrae MA. The rotavirus genome. Curr Top Microbiol Immunol 1994; 185 : 31-66.
12. Pedley S, Bridger JC, Chasey D, McCrae MA. Definition of two new groups of atypical rotaviruses. J Gen Virol 1986; 67 : 131-7.
13. Greenberg HB, Flores J, Kalica AR, Wyatt RG, Jones R. Gene coding assignments for growth restriction, neutralization and subgroup specificities of the Wa and DS-I strains of human rotavirus. J Gen Virol 1983; 64 : 313-20.
14. Hoshino Y, Gorziglia M, Valdesuso J, Askka J, Glass RI, Kapikian AZ. An equine rotavirus (FI-14 strain) which bears both subgroup I and subgroup II specificities on its VP6. Virology 1987; 157 : 488-96.
15. Svensson L, Grahnquist L, Pettersson CA, Grandien M, Stintzing G, Greenberg HB. Detection of human rotaviruses which do not react with subgroup I and II specific monoclonal antibodies. J Clin Microbiol 1988; 26 : 1238-40.
16. Browning GF, Fitzgerald TA, Chalmers RM, Snodgrass DR. A novel group A rotavirus G serotypes : serological and genomic characterization of equine isolate F 123. J Clin Microbiol 1991; 29 : 2043-6.
17. Taniguchi K, Urasawa T, Kobayashi N, Gorziglia M, Urasawa S. Nucleotide sequence of VP4 and VP7 genes of human rotaviruses with subgroup 1 specificity and long RNA pattern : implication for new G serotype specificity. J Virol 1990; 64 : 5640-4.
18. Gorziglia M, Larralde G, Kapikian AZ, Chanock RM. Antigenic relationship among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci USA 1990; 87 : 7155-9.
19. Hoshino Y, Serono MM, Midthun K, Flores J, Kapikian AZ, Chanock RM. Independent segregation of two antigenic specificities (VP3 & VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci USA 1985; 82 : 8701-4.
20. Qian Y, Green KY. Human rotavirus strain 69M has a unique VP4 as determined by amino acid sequence analysis. Virology 1991; 182 : 407-12.
21. Taniguchi K, Nishikawa K, Urasawa T, Urasawa S, Midthun K, Kapikian AZ et al. Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes. J Virol 1989; 63 : 4101-6.
22. Kapikian AZ, Flores J, Vesikari T, Ruuska T, Modore HP, Green KY et al. Recent advances in development of a rotavirus vaccine for prevention of severe diarrhoeal illness of infants and young children. In : Mestecky J, Blair C, Ogra PL, editors. Immunology of milk and the neonate New York : Plenum Press; 1992.
23. Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhoea. J Infect Dis 1993; 168 : 282-7.
24. Wyatt RG, James WD, Bohl EH, Theil KW, Saif LJ, Kalica AR et al. Human rotavirus type 2: Cultivation in vitro. Science 1980; 207 : 189-91.
25. Shaw RD, Fong KJ, Losonsky GA, Lavine MM, Maldonado Y, Yolber R et al. Epitope-specific immune responses to rotavirus vaccination. Gastroenterology 1987; 93 : 941-50.
26. Vesikari T, Isolauri E, D'Hondt E, Delem A, Andre FE, Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1984; i : 977-81.
27. Ruuska T, Vesikari T, Delem A, Andre FE, Beards GM, Flewett TH. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: Correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period. Scand J Infect Dis 1990; 22 : 269-78.
28. Vesikari T, Varis T, Green K, Flores J, Kapikian AZ. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity. Vaccine 1991; 9 : 334-9.
29. Vesikari T, Ruuska T, Delem A, Andre F, Beards G, Flewett T. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Acta Paediatr Scand 1991; 80 : 173-80.
30. Vesikari T. Clinical trials of live oral rotavirus vaccines: the Finnish experience. Vaccine 1993; 11 : 255-61.
31. Lanata CF, Black RE, del Aguila R, Gil A, Verastegie H, Gerua G et al. Protection of Peruvian children against rotavirus diarrhoea of specific serorypes by one, two or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis 1989; 159 : 452-9.
32. Hanlon P, Hanlon L, Marsh V, Byass P, Sherton, F, Hassan-King M et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1987; i : 1342-5.
33. De Mol P, Zissis G, Butzler JP, Mutwewingabo A, Andre FE. Failure of live, attenuated rotavirus vaccine. Lancet 1986; ii : 108.
34. Santosham M, Letson GW, Wolff M, Reid R, Gahagan S, Adams R. et al. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 1991; 163 : 483-7.
35. Flores J, Perez-Schael I, Gonzalez M, Garcia D, Perez, M, Daoud N et al. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 1987; i : 882-4.
36. Perez-Schael I, Blanco M, Vilar M, Garcia D, White L, Gonzalez R et al. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol 1990; 28 : 553-8.
37. Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosetski D et al. Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J 1988; 7 : 645-50.
38. Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ. Rhesus rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age. Am J Dis Child 1990; 144 : 285-9.
39. Rennels MB, Losonsky GA, Young AE, Shindledecker CL, Kapikian AZ, Levine MM et al. An efficiency trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group. Am J Dis Child 1990; 144 : 601-4.
40. Ukae S, Nakata S, Adachi N, Kogawa K, Chiba S. Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype-1 rotavirus. Vaccine 1994; 12 : 933-9.
41. Clark HF, Borian FE, Bell LM, Modosto K, Goulvea V, Plotkin SA. Protective effect of WC3 vaccine against rotavirus diarrhoea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988; 158 : 570-87.
42. Bernstein DI, Smith VE, Sander DS, Pax KA, Schiff GM, Ward RL. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 1990; 162 : 1055-62.
43. Ward RL, Sander DS, Schiff GM, Bernstein DI. Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis 1990; 162 : 1298-303.
44. Georges-Courbot MC, Monges J, Siopathis MR, Roungou JB, Gresenguet G et al. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 1991; 142 : 405-11.
45. Flores J, Perez-Schael I, Blanco M, White L, Garcia D, Vilar M et al. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine. Lancet 1990; ii : 330-4.
46. Clark HF, Borian FE, Plotkin SA. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. J Infect Dis 1990; 161 : 1099-104.
47. Treanor JJ, Clark HF, Pichichero M, Christy C, Gouvea V, Schrager D et al. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatr Infect Dis J 1995; 14 : 301-7.
48. Bernstein DI, Glass RI, Rodger G, Davidson BL, Sack DA. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccine in US children. JAMA 1995; 273 : 1191-6.
49. Simasathien S, Migasena S, Samakoses R, Pithisuttitham P, Sangaroon P, Aree C et al. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine. Pediatr Infect Dis J 1994; 13 : 590-6.
50. Rennels MB, Wasserman SS, Glass RI, Keane VA. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccine in breast fed and non breast fed children. Pediatrics 1995; 96: 1132-6.
51. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of national multicentre trial United States Rotavirus vaccine efficacy group. Pediatrics 1996; 97 : 7-13.
52. Wright PF, King J, Araki K, Kondo Y, Thompson J, Tollefson SJ et al. Simultaneous administration of two human - rhesus rotavirus reassortant strain of VP7 serotype 1 and 2 specificity to infants & young children. J Infect Dis 1991; 164 : 271-6.
53. Migasena S, Simasathien S, Samkoses R, Pitisuttitham P, Sangaroon P, Van Steenis et al. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 1995; 13 : 168-74.
54. Sabara M, Parker M, Aha P, Coscoc, Gribrowns E, Parrons E et al. Assembly of double-shelled rotavirus-like particles by simultaneous expression of recombinant VP6 and VP7 proteins. J Virol 1991; 65 : 6994-7.
55. McCrae MA, Mc Corquodale JG. Expression of a major bovine rotavirus neutralization antigen (VP7c) in Escherichia coli. Gene 1987; 55 : 9-18.
56. Salas-Vidal E, Plebanski M, Castro S, Peraleo G, Mata E, Lopez S et al. Synthesis of the surface glycoprotein of rotavirus SA11 in the aroA strain of Salmonella typhimurium SL 3261. Res Microbiol 1990; 141 : 883-6.
57. Andrew ME, Boyle DB, Coupar BEH, Reddy D, Bellamy AR, Both GW. Vaccinia rotavirus VP7 recombinants protect mice against rotavirus induced diarrhoea. Vaccine 1992; 10 : 185-91.
58. Gunn PR, Sato F, Powell KF, Bellamy AR, Napar JR, Hording DR et al. Rotavirus neutralizing protein VP7 antigenic determinants investigated by sequence analysis and peptide synthesis. J Virol 1985; 54 : 791-7.
59. Streckert HJ, Brussow H, Werchau H. A synthetic peptide corresponding to the cleavage region of VP3 from rotavirus SA11 induces neutralizing antibodies. J Virol 1988; 62 : 4265-69.
60. Arias CF, Gracia G, Lopez S. Priming for rotavirus neutralizing antibodies by a VP4 protein derived synthetic peptide. J Virol 1989; 63 : 5393-8.
61. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995; 13 : 310-2.
62. Offit PA, Khoury CA, Moser CA, Clark HF, Kim JE, Speaker TJ. Enhancement of rotavirus immunogenicity by microencapsulation. Virology 1994; 203 : 134-43.
63. Green KY, Taniguchi K, Mackow ER, Kapikian AZ. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees : implications for vaccine development. J Infect Dis 1990; 161 : 667-79.
64. Hoshino Y, Saif LJ, Sereno MM, Chanock RM, Kapikian AZ. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J Virol 1988; 62 : 744-8.
65. Brussow H, Walther I, Fryder V, Sidoti J, Bruttin A. Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus. J Gen Virol 1988; 69 : 1647-58.
66. Snodgrass DR, Fahey KJ, Wells PW, Campbell I, Whitelaw A. Passive immunity in calf rotavirus : maternal vaccination increases and prolongs immunoglobulin G1 antibody secretion in milk. Infect Immun 1980; 28 : 344-9.
67. Snodgrass DR, Campbell I, Mwenda JM, Chege G, Suleman MA, Morein B et al. Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination. Vaccine 1995; 13 : 408-13.
68. Dunn SJ, Flore J, Werner RL, Cross TL, Broome RL, Rugger FM et al. Immunogenicity, antigenicity and protective efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(I)* and VP8* from rhesus rotavirus. Arch Virol 1995; 140 : 1969-78.
69. Gouvea V, Brantly M. Is rotavirus a population of reassortant? Trends in Microbiol 1995; 3 : 159-62.
70. Lizuka M, Kaga E, Chiba M, Masamune O, Gema Cr, Nakagomi O. Serotype G6 human rotavirus sharing a conserved genetic constellation with natural reassortants between members of the bovine and AU-1 genogroup. Arch Virol 1994; 135 : 427-32.
71. Das BK, Gentsch JR, Hoshino Y, Ishida SI, Nakagomi O, Bhan M, Kumar R et al. Characterization of the G serotype and genogroup of New Delhi newborn rotavirus strain 116E. Virology 1993; 197 : 99-101.
72. Das M, Dunn SJ, Woode GN, Greenberg HB, Rao CD. Both surface proteins (VP4 & VP7) of an asymptomatic neonatal rotavirus strain (L321) have high levels of sequence identity with the homologous proteins of aserotype 10 bovine rotavirus. Virology 1993; 194 : 374-9.
73. Gentsch JR, Das BK, Jiang B, Bhan MK, Glass RI. Similarity of the VP4 protein of human rotavirus strain 116E to that of bovine B223 strain. Virology 1993; 194 : 424-30.
74. Ghosh SK, Naik TN. Detection of large number of subgroup I human rotaviruses with a 'long' RNA electropherotypes. Arch Virol 1989; 105 : 119-27.
75. Urasawa T, Taniguchi K, Kobayashi N, Mise K, Hasegawa A, Yamazi Y et al. Nucleotide sequence of VP4 and VP7 genes of a unique human rotavirus strain MC35 with subgroup I and serotype 10 specificity. Virology 1993; 766-71.
76. Krishnan T, Burke B, Shen S, Naik TN, Desselberger U. Molecular epidemiology of human rotavirus in Manipur : Genome analysis of rotaviruses of long electropherotype and subgroup I. Arch Virol 1994; 134 : 279-92.
77. Nakagomi O, Nakagomi T. Genetic diversity and similarity among mammalian rotaviruses in relation to interspecies transmission of rotavirus. Arch Virol 1991; 120 : 43-55.
78. Vonsover A, Shif I, Silberstein I, Rudich H, Aboudy Y, Mendelson E. et al. Identification of feline- and canine-like rotaviruses isolated from humans by restriction fragment length polymorphism assay. J Clin Microbiol 1993; 31 : 1783-87.
79. Ward RL, Nakagomi O, Knowlton DR, McNeal MM, Nakagomi T, Clemens JD et al. Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol 1990; 64 : 3219-25.
80. Bellinzoni RB, Mattion NM, Matson DO, Blackhall J, La Torre' JL, Scodeller EA et al. Porcine rotaviruses antigenically related to human rotavirus serotypes 1 and 2. J Clin Microbiol 1990; 28 : 633-6.
81. Nakagomi O, Isegawa Y, Ward RL, Knowlton DR, Kaga E, Nakagomi T et al. Naturally occurring dual infection with human and bovine rotaviruses as suggested by recovery of G1P8 and G1P5 rotaviruses from a single patient. Arch Virol 1994: 137 : 381-8.
82. Lubeck MD, Palese P, Schulman JL. Nonrandom association of parental genes in influenza A virus recombinant. Virology 1979; 95 : 269-74.
83. Pringle CR, Lee JF, Clark W, Elliott RM. Genome subunit reassortment among bunyaviruses analysed by dot hybridization using molecularly cloned complementary DNA probes. Virology 1984; 135 : 244-56.
84. Ramig RF, Ward RL. Genomic segment reassortment in rotaviruses and other reoviridae. Adv Virus Res 39 : 163-204.
85. Beards GM, Desselberger U, Flewett TH. Temporal and geographical distributions of human rotavirus serotypes 1983 to 1988. J Clin Microbiol 1989; 27 : 2827-33.
86. Brown DWG, Mathan MM, Mathew M, Martin R, Beards GM, Mathan VI. Rotavirus epidemiology in Vellore, South India : Group, subgroup, serotype and electropherotype. J Clin Microbiol 1988; 26 : 2410-4.
87. Matson DO, Estes MK, Burns JW, Greenberg HB, Taniguchi K, Urasawa S. Serotype variation of human group A rotaviruses in two regions of the USA. J Infect Dis 1990; 162 : 605-14.
88. Noel JS, Beards GM, Cubitt WD. Epidemiological survey of human rotavirus serotypes and electropherotypes in young children admitted to two hospitals in N.E. London from 1984 to 1990. J Clin Microbiol 1991 ; 29 : 2213-9.
89. Ramachandran M, Das BK, Vij A, Kumar R, Bhambai SS, Kesari N et al. Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol 1996; 34 : 436-9.
90. Maunula L, Van Bonsdorff CH. Rotavirus serotypes and electropherotypes in Finland from 1986-1990. Arch Virol 1995; 140 : 877-90.
91. Green KY, James Jr, HD Kapikian AZ. Evaluation of three panels of monoclonal antibodies for the identification of human rotavirus VP7 serotypes by ELISA. Bull WHO 1990; 68 : 601-10.
92. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretion. J Clin Immunol 1987; 7 : 265-76.
93. Mc Neal MM, Sheridan JF, Ward RL. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology 1992; 191 : 150-7.
94. Ward RL, McNeal MM, Sheridan JI. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology 1992; 188 : 57-66.
95. McNeal MM, Rosemary L, Broome, Word RL. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology 1994; 204: 642-50.
96. Glass RI, Gentsch JR, Ivanoff B. New lessons for rotavirus vaccines: Science 1996; 272 : 46-8.
97. Ball JM, Tian P, Zeng C, Q-Y, Morris AP, Estes MK. Age-dependent diarrhoea ,induced by a rotaviral nonstructural glycoprotein. Science 1996; 272 : 101-4.
98. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996; 272 : 104-7.